|Articles|August 19, 2016

WAVE Life Sciences Recruits Former Shire Exec as CFO

August 19, 2016

Genetic medicines company WAVE Life Sciences Ltd. (Cambridge, MA) announced that it has appointed Keith Regnante as the company’s Chief Financial Officer.

Mr. Regnante was formerly VP of Finance at Shire where he oversaw finance for R&D. Earlier in his career he was a consultant with Boston Consulting Group.

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

WAVE Life Sciences Recruits Former Shire Exec as CFO

Related Content

“AI as Reinvention”: Transforming the Business of Medicine

Utilizing 100-Percent Domestic Additive Manufacturing: Q&A with Kyle Smith

Insilico Announces Collaboration with SK Biopharmaceutical for AI-Powered CNS Treatment

Additive Manufacturing's Application in Pharma and Biotech

Expanding the Vaccine Landscape with New Technologies: Q&A with Silvia Taylor

Trending on PharmExec

The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market

Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion

Catalent Announces Expanded Partnership with Nanoscope Therapeutics

Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last

Pharmaceutical Executive Daily: The Changing Reality of Pharmaceutical Commercialization